v3.26.3
CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS’ EQUITY - USD ($)
$ in Millions
Total
Total Crown Equity
Common Stock
Paid-in Capital
Retained Earnings
Accumulated Other Comprehensive Loss
Noncontrolling Interests
Balance at beginning of period at Dec. 31, 2024 $ 3,228 $ 2,756 $ 594 $ 0 $ 3,624 $ (1,462) $ 472
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net income (loss) 227 193     193   34
Other comprehensive income (35) (35)       (35)
Dividends declared (58) (30)     (30)   (28)
Restricted stock awarded 0 0 1 (1)      
Stock-based compensation 14 14   14      
Common stock issued 1 1   1      
Common stock repurchased (205) (205) (11) (14) (180)    
Balance at end of period at Mar. 31, 2025 3,172 2,694 584 0 3,607 (1,497) 478
Balance at beginning of period at Dec. 31, 2024 3,228 2,756 594 0 3,624 (1,462) 472
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net income (loss) 682            
Other comprehensive income 36         35  
Balance at end of period at Sep. 30, 2025 3,499 3,016 579 0 3,864 (1,427) 483
Balance at beginning of period at Mar. 31, 2025 3,172 2,694 584 0 3,607 (1,497) 478
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net income (loss) 216 181     181   35
Other comprehensive income 43 41       41 2
Dividends declared (64) (30)     (30)   (34)
Restricted stock awarded 0 0 1 (1)      
Stock-based compensation 12 12   12      
Common stock repurchased (7) (7) (1) (6)      
Balance at end of period at Jun. 30, 2025 3,372 2,891 584 5 3,758 (1,456) 481
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net income (loss) 239 214     214   25
Other comprehensive income 28 29       29 (1)
Dividends declared (52) (30)     (30)   (22)
Stock-based compensation 11 11   11      
Common stock repurchased (105) (105) (5) (22) (78)    
Purchase of noncontrolling interest 6 6   6      
Balance at end of period at Sep. 30, 2025 3,499 3,016 579 0 3,864 (1,427) 483
Balance at beginning of period at Dec. 31, 2025 3,480 2,999 569 0 3,812 (1,382) 481
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net income (loss) 206 175     175   31
Other comprehensive income (17) (17)       (17)  
Dividends declared (56) (39)     (39)   (17)
Restricted stock awarded 0 0 2 (2)      
Stock-based compensation 13 13   13      
Common stock repurchased (214) (214) (10) (11) (193)    
Balance at end of period at Mar. 31, 2026 3,412 2,917 561 0 3,755 (1,399) 495
Balance at beginning of period at Dec. 31, 2025 3,480 2,999 569 0 3,812 (1,382) 481
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net income (loss) 743            
Other comprehensive income (26)         (24)  
Balance at end of period at Sep. 30, 2026 3,461 2,935 543 0 3,798 (1,406) 526
Balance at beginning of period at Mar. 31, 2026 3,412 2,917 561 0 3,755 (1,399) 495
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net income (loss) 276 245     245   31
Other comprehensive income 37 40       40 (3)
Dividends declared (62) (38)     (38)   (24)
Restricted stock awarded 0 0 1 (1)      
Stock-based compensation 10 10   10      
Common stock issued 1 1   1      
Common stock repurchased (308) (308) (15) (10) (283)    
Balance at end of period at Jun. 30, 2026 3,366 2,867 547 0 3,679 (1,359) 499
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net income (loss) 261 225     225   36
Other comprehensive income (46) (47)       (47) 1
Dividends declared (48) (38)     (38)   (10)
Stock-based compensation 11 11   11      
Common stock repurchased (83) (83) (4) (11) (68)    
Balance at end of period at Sep. 30, 2026 $ 3,461 $ 2,935 $ 543 $ 0 $ 3,798 $ (1,406) $ 526